petesicatib

cathepsin S inhibitor

Also Known As:

(4R)-N-(1-Cyanocyclopropyl)-4-((4-(1-methyl-1H-pyrazol-4-yl)-2-(trifluoromethyl)phenyl)sulfonyl)-1-((1-(trifluoromethyl)cyclopropyl)carbonyl)-L-prolinamide; 2-Pyrrolidinecarboxamide, N-(1-cyanocyclopropyl)-4-((4-(1-methyl-1H-pyrazol-4-yl)-2-(trifluoromethyl)phenyl)sulfonyl)-1-((1-(trifluoromethyl)cyclopropyl)carbonyl)-, (2S,4R)-; RO5459072

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - petesicatib: 1
  - Pyrrolidines: 115
    - petesicatib: 1

Experts

1.	Bannert, Bettina: 1 article (01/2019)
2.	Daoudlarian, Douglas: 1 article (01/2019)
3.	Hargreaves, Patrick: 1 article (01/2019)
4.	Kolb, Fabrice A: 1 article (01/2019)
5.	Kyburz, Diego: 1 article (01/2019)
6.	Manchester Young, Marianne: 1 article (01/2019)
7.	Manigold, Tobias: 1 article (01/2019)
8.	Reis, Bernhard: 1 article (01/2019)
9.	Theron, Michel: 1 article (01/2019)
10.	Tiaden, Andre: 1 article (01/2019)

Related Diseases

1.	Human Influenza (Influenza) 01/01/2019 - "In addition, antigen (SS-A (60kD), SS-B, influenza H3N2, tetanus toxoid and SEB)-specific T cell responses were examined using ex vivo IFN-γ/IL-17 Dual ELISPOT and Bromdesoxyuridin (BrdU) proliferation assays in the presence or absence of RO5459072. "

Related Drugs and Biologics

1.	Tetanus Toxoid (Vaccine, Tetanus)
2.	Bromodeoxyuridine (BrdU)
3.	Antigens